|View printer-friendly version|
|June 25, 2002 4:16 p.m.|
|Teva Closes Acquisition of Honeywell Pharmaceutical Fine Chemicals S.r.l in Italy|
Jerusalem, Israel, June 25, 2002 - Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) announced today, that further to its announcement dated May 21, 2002, it has completed the acquisition of Honeywell Pharmaceutical Fine Chemicals S.r.l. (HPFC S.r.l.), an Italian subsidiary of Honeywell International Inc. (NYSE:HON) and a producer of active pharmaceutical ingredients (API). Teva will integrate HPFC S.r.l.'s two manufacturing facilities in Northern Italy, which will operate under the name Teva Pharmaceutical Fine Chemicals S.r.l (or Teva PFC), with its own two existing API facilities in the area. No additional details were disclosed.